Drug recall · January 8, 2014
0.5% Bupivacaine HCl and Epinephrine 1:200 recall
Why: Lack of assurance of sterility; equipment failure led to potential breach in asceptic process.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
0.5% Bupivacaine HCl and Epinephrine 1:200,000 Inj., 50 mL, Multiple-dose Fliptop Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045. NDC #0409-9046-01.
- Lots / codes
Lot #32-484-EV, 32-485-EV Exp: 2/2015.
- Quantity
- 65109 vials
- Company
- Hospira Inc., Lake Forest, IL
- Distribution
- US Nationwide.
- Initiated
- October 11, 2013 · Voluntary: Firm initiated
- Classified
- January 2, 2014
- Reported
- January 8, 2014
- Ended
- November 10, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Epinephrine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.